(Total Views: 246)
Posted On: 02/19/2021 6:51:23 PM
Post# of 36541
Joe said this in the CC:
We're very excited about that work; they've already hired up to 25 people
according to them as they've told us; they also have ten members of the
Chinese CDC that their scientists will be working on our programs. PPD
China--our partner PPD worldwide, their Chinese office--is already
working with the new entity and our partners to design the clinical trials
in China. They just got their estimates to do Phase 1, Phase 2, Phase 3;
and after next week, once we get our final readout on the complete
vaccine, we will ship them Phase 1 and 2 materials so they can start their
trials immediately.
They believe that they can do their trials a lot quicker than we can; the
CDC of China is one of our partners--they're our technical partner there--
so, they're going to be spearheading a lot of that effort with their
scientists to get this through the clinic as quickly as possible. So, that's
very exciting for us; we'll also have access to the data they'll do in FDAassociated guidelines, so we'll be able to utilize some of that data as well
as they get moving.
We're very excited about that work; they've already hired up to 25 people
according to them as they've told us; they also have ten members of the
Chinese CDC that their scientists will be working on our programs. PPD
China--our partner PPD worldwide, their Chinese office--is already
working with the new entity and our partners to design the clinical trials
in China. They just got their estimates to do Phase 1, Phase 2, Phase 3;
and after next week, once we get our final readout on the complete
vaccine, we will ship them Phase 1 and 2 materials so they can start their
trials immediately.
They believe that they can do their trials a lot quicker than we can; the
CDC of China is one of our partners--they're our technical partner there--
so, they're going to be spearheading a lot of that effort with their
scientists to get this through the clinic as quickly as possible. So, that's
very exciting for us; we'll also have access to the data they'll do in FDAassociated guidelines, so we'll be able to utilize some of that data as well
as they get moving.
(2)
(0)
Scroll down for more posts ▼